Company profile for Curia

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Curia is a global contract research, development and manufacturing organization (CDMO), offering products and services across the drug development spectrum to help our partners turn their ideas into real-world impact. We partner closely with pharmaceutical and biotechnology companies to boost business performance and improve patients’ lives. From early discovery and development through manufacturing and commercialization, ou...
Curia is a global contract research, development and manufacturing organization (CDMO), offering products and services across the drug development spectrum to help our partners turn their ideas into real-world impact. We partner closely with pharmaceutical and biotechnology companies to boost business performance and improve patients’ lives. From early discovery and development through manufacturing and commercialization, our suite of custom solutions allows us to tailor every engagement to your precise needs, whether that’s an independent project or an opportunity that cuts across the drug continuum.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
26 Corporate Circle, Albany, New York 12203
Telephone
Telephone
+1 518.512.2000
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

CPhI South East Asia

Not Confirmed

envelop Contact Supplier

CPhI South East Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

INTERVIEW #SpeakPharma

[Sponsored by another company]
Alchem NicSelect™ grants customers royalty-free access to T-MAX™ tech for 3-in-1 vape satisfaction in flavour-restricted markets
With increasing flavour bans in key markets, vaping brands are facing significant challenges in providing satisfying alternatives to vapers and smokers looking to transition. Recognising this need, Alchem NicSelect™ is making a bold move by offering its key customers royalty-free and unrestricted geographical access to its revolutionary T-MAX™ technology.“At Alchem NicSelect™, we understand the urgency for vaping brands to adapt to new regulations without compromising on satisfaction. By offering royalty-free access to T-MAX™ technology, we empower our customers to provide the closest cigarette-like experience possible, even in markets with strict flavour restrictions,” said Riccardo Santambrogio, Europe Sales Manager.HIGHLIGHTS// offering royalty-free access to T-MAX™ technology/ unrestricted geographical access/ closest cigarette-like experience Addressing the biggest barrier: Nicotine satisfactionOne of the primary reasons many vapers are dissatisfied and smokers struggle to switch to vaping is that traditional nicotine solutions fail to replicate the rapid satisfaction provided by cigarettes. Nicotine replacement therapies (NRTs) and even conventional vaping products often lack the immediate nicotine hit, throat feel, and overall experience that smokers are accustomed to. T-MAX™ solves this problem by engineering a nicotine experience that closely mimics cigarette consumption without relying on flavours.T-MAX™ provides a unique 3-in-1 approach:1. The Speed of a Cigarette – Rapid nicotine delivery and rush within seconds for immediate satisfaction.2. The Power of Nicotine Salts – A stronger perceived nicotine effect without exceeding legal limits (20 mg/ml nicotine limit under the European Tobacco Products Directive). With T-MAX™, 8 mg/ml feels like 20 mg/ml, and 14 mg/ml feels like 40 mg/ml.3. The Throat Hit of Freebase Nicotine – Especially in a flavour-free formulation, the combined ingredients in T-MAX™ deliver an even more satisfying throat feel than expected from nicotine base, much closer to and more familiar with a cigarette throat feel that habitual smokers recognise.HIGHLIGHTS// unique 3-in-1 approach/ rush within seconds/ stronger perceived nicotine effect without exceeding legal limits/ more satisfying throat feel that habitual smokers recogniseNo flavour, but not less satisfyingWhile flavours have traditionally played a role in vaping adoption, market realities are shifting. With flavour bans spreading across regions, brands need solutions that deliver satisfaction without relying on taste. Consumer research has shown that T-MAX™ performs exceptionally well even without added flavours. Since most cigarette smokers do not smoke for the tobacco flavour but rather for the nicotine hit and habitual experience, T-MAX™ provides a viable alternative that aligns with new regulatory landscapes.HIGHLIGHTS// flavour bans spreading across regions/ T-MAX™ performs exceptionally well even without added flavoursEmpowering vape brands with free access to T-MAX™By granting customers royalty-free access to the T-MAX™ technology, Alchem NicSelect™ is removing barriers for vaping brands and original equipment manufacturers (OEMs) looking to adapt to regulatory changes. This open-access approach ensures that manufacturers can integrate T-MAX™ into their product lines without additional costs, allowing them to offer superior nicotine satisfaction in markets where flavours are no longer an option.HIGHLIGHTS// removing barriers for vaping brands and OEMs looking to adapt/ manufacturers can integrate T-MAX™ into product lines without additional costsThe future of vaping in restricted marketsWith T-MAX™, the vaping industry has a powerful tool to retain customers and convert smokers who have struggled with traditional vaping products. By delivering the key elements of cigarette satisfaction — without combustion or flavours — T-MAX™ is set to redefine what a satisfying vape experience means in a post-flavour-ban world.“Our commitment to innovation and accessibility means we are providing our customers with the solutions they need to navigate an evolving regulatory landscape. T-MAX™ allows brands to offer a highly satisfying experience that mimics smoking without relying on flavours. The message is clear: no flavour, but not less satisfying”, added Santambrogio.HIGHLIGHTS// powerful tool to retain customers and convert smokers/ delivering the key elements of cigarette satisfaction without combustion or flavours/ no flavour, but not less satisfying

Impressions: 1235

https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets

Radio Compass
06 May 2025

VLOG #PharmaReel

[Sponsored by another company]
This PharmaReel showcases Allsino Pharmaceutical, a company that provides GMP-certified RSMs and APIs to global pharma companies, specializing in peptides, oligonucleotides, and small molecule CDMO services. Allsino has a presence in the US, EU, China and Japan.

Impressions: 1215

read-more

DATA COMPILATION #PharmaFlow

[Sponsored by another company]
J&J’s Intra‑Cellular buyout, BMS’ oncology gambit, Sanofi’s Blueprint acquisition drive mega deals in H1 2025
The pharmaceutical industry has witnessed a wave of mergers, acquisitions, and strategic partnerships so far in the first half (H1) of 2025, with deal values exceeding US$ 170 billion.PharmaCompass’ data shows oncology alone accounted for nearly US$ 47 billion in deal value, followed by US$ 18 billion each in immunology and psychiatry, US$ 17 billion in nutrition/weight loss and US$ 7 billion in neurology.Pharma majors such as Johnson & Johnson and Bristol Myers Squibb led with two deals worth over US$ 10 billion each. Sanofi executed a series of deals in the immunology and neuro-inflammation space. And Eli Lilly stood out for its aggressive dealmaking, which spanned oncology, pain, RNA therapies, and AI-driven oligonucleotides. In all, it signed seven deals worth over US$ 1 billion each. View Pharma & Biotech Acquisitions, Deals & Agreements in 2025 as of June 14 (Free Excel Available)H1 records several mega deals as J&J buys Intra-Cellular, BMS ties up with BioNTech, Sanofi acquires BlueprintJohnson & Johnson dominated headlines with its US$ 14.6 billion acquisition of Intra-Cellular Therapies in January 2025. This marks the largest biopharma deal since Novo Nordisk’s US$ 16.5 billion acquisition of Catalent in February 2024. This acquisition positions J&J as a formidable player in the neuroscience space. Bristol Myers Squibb entered into a US$ 11.1 billion partnership with BioNTech. The deal structure — US$ 3.5 billion in unconditional payments and up to US$ 7.6 billion in milestone payments — demonstrates BMS’ confidence in BNT327, a next-generation bispecific antibody in phase 3 trials for treating extensive stage small cell lung cancer and non-small cell lung cancer.Sanofi acquired Blueprint Medicines for US$ 9.5 billion in order to enhance its rare disease portfolio. The French drugmaker is also creating a comprehensive immunology portfolio. The company signed a US$ 1.9 billion deal for Dren Bio’s DR-0201 bispecific antibody for autoimmune diseases. Sanofi also acquired Vigil Neuroscience for US$ 470 million for its phase 2-ready Alzheimer’s disease candidate. Additionally, the drugmaker secured a US$ 1.84 billion global license agreement with Earendil Labs for two next-generation bispecific antibodies.Pfizer’s US$ 6.05 billion partnership with 3SBio provides it global licensing rights (excluding China) for SSGJ-707, a bispecific antibody currently undergoing multiple clinical trials in China for non-small cell lung cancer, metastatic colorectal cancer, and gynecological tumors. View Pharma & Biotech Acquisitions, Deals & Agreements in 2025 as of June 14 (Free Excel Available) Obesity gold rush sees Roche, AbbVie, Sciwind ink deals; Novo pledges over US$ 5 bn across three dealsThe obesity therapeutics market has triggered intense competition among pharmaceutical giants. Roche’s US$ 5.3 billion partnership with Zealand Pharma is focused on petrelintide, an amylin analog designed to preserve lean mass better than existing GLP-1-based treatments. The collaboration combines petrelintide with Roche’s dual GLP-1/GIP receptor agonist CT-388, creating a differentiated obesity treatment.Market leader Novo Nordisk has promised over US$ 5 billion across three major obesity deals in 2025. The US$ 2.2 billion Septerna collaboration targets oral small molecule medicines for obesity and cardiometabolic diseases.Novo signed a separate US$ 2 billion agreement with China’s United Biotechnology for UBT251, a triple agonist for GLP-1, GIP, and glucagon receptors in phase 2 clinical development for obesity, type 2 diabetes, and other diseases. The company’s third major deal, a US$ 1 billion partnership with Lexicon Pharmaceuticals, provides it access to LX9851, a molecule in preclinical development for obesity and associated metabolic disorders.Sciwind Biosciences secured a US$ 2.5 billion global licensing and collaboration agreement with Verdiva Bio Limited for the global development and commercialization of a portfolio of metabolic diseases therapies. AbbVie entered the amylin arena through its US$ 2.2 billion Gubra partnership for GUB014295, a candidate in phase 1 trials for treating obesity. View Pharma & Biotech Acquisitions, Deals & Agreements in 2025 as of June 14 (Free Excel Available) Molecular glue degraders draw investments; Lilly signs seven deals over US$ 1 billion eachMolecular glue degraders have emerged as a transformative therapeutic modality, attracting significant investment across multiple partnerships. AbbVie’s US$ 1.64 billion collaboration with Neomorph leverages the biotech’s leading molecular glue discovery platform for oncology and immunology applications.Genentech’s potential US$ 2.1 billion partnership with Orionis Biosciences focuses on small-molecule monovalent glue medicines for novel and challenging oncology targets. This is the second partnership between the two companies, following their initial 2023 collaboration.Eli Lilly has collaborated with Magnet Biomedicine, utilizing Magnet’s TrueGlue discovery platform for oncology applications. The deal could be worth up to US$ 1.3 billion.Eli Lilly has emerged as one of 2025’s most active dealmakers, with approximately seven deals exceeding US$ 1 billion each. The company’s US$ 2.5 billion Scorpion Therapeutics acquisition provides access to STX-478, an experimental oral therapy in early-stage trials for breast cancer and advanced solid tumors, potentially addressing 30 to 40 percent of hormone-positive breast cancer patients.On June 17, Lilly announced the acquisition of gene-editing startup Verve Therapeutics for US$ 1.3 billion. Lilly’s US$ 1 billion SiteOne acquisition announced in May brings STC-004, a phase 2-ready non-opioid chronic pain treatment to its pipeline. Other partnerships announced by Lilly include a US$ 1.4 billion capsid licensing deal with Sangamo for central nervous system disease genomic medicines and a US$ 1.3 billion collaboration with South Korean company Rznomics for RNA-based hearing loss treatments. Lilly has also strengthened its oligonucleotide pipeline through a potential US$ 1 billion collaboration with Creyon Bio for AI-designed oligonucleotide therapies targeting RNA. View Pharma & Biotech Acquisitions, Deals & Agreements in 2025 as of June 14 (Free Excel Available) Merck KGaA acquires SpringWorks for US$ 3.9 bn; Novartis buys out Anthos for US$ 3.1 bnAstraZeneca signed a US$ 5.3 billion AI-led research agreement with China’s CSPC Pharmaceuticals Group to advance the discovery of novel oral candidates for immunological diseases. Merck KGaA acquired SpringWorks for US$ 3.9 billion in April, which gave it access to two FDA-approved therapies — Ogsiveo (nirogacestat), the first and only approved therapy for adult patients with progressing desmoid tumors requiring systemic treatment, and Gomekli (mirdametinib), the first and only FDA-approved therapy for adults and children with neurofibromatosis type 1-associated plexiform neurofibromas.Novartis’ US$ 3.1 billion Anthos Therapeutics acquisition centered around abelacimab, a potential first-in-class monoclonal antibody currently in three phase 3 studies for stroke and systemic embolism prevention in atrial fibrillation patients.GSK’s US$ 2 billion acquisition of Boston Pharmaceuticals’ efimosfermin targets steatotic liver disease (fatty liver disease). The medicine is also in clinical development for MASH treatment. GSK’s second major deal involved the US$ 1.15 billion acquisition of US biotech IDRx, strengthening its gastrointestinal cancer portfolio.The pharma industry also drew some private equity interest as Bain Capital acquired Japan’s Mitsubishi Tanabe Pharma from Mitsubishi Chemical Group for US$ 3.3 billion. View Pharma & Biotech Acquisitions, Deals & Agreements in 2025 as of June 14 (Free Excel Available) Our viewDespite an uncertain geopolitical environment, the year has seen a surge in M&As and dealmaking in the first half of 2025. However, a sizable chunk of the acquisitions were bolt-on transactions, indicating that companies are not ready to take on risks, and are buying out smaller players who strategically fit into their operations. Going forward, there are indications that M&A activity will stay strong throughout 2025. 

Impressions: 2783

https://www.pharmacompass.com/radio-compass-blog/j-j-s-intra-cellular-buyout-bms-oncology-gambit-sanofi-s-blueprint-acquisition-drive-mega-deals-in-h1-2025

#PharmaFlow by PHARMACOMPASS
19 Jun 2025

NEWS #PharmaBuzz

read-more
read-more

https://www.contractpharma.com/breaking-news/curia-expands-global-network-of-sterile-fill-finish-sites/

CONTRACTPHARMA
17 Mar 2025

https://www.globenewswire.com/news-release/2025/03/17/3043747/0/en/Curia-Announces-Expansions-to-Global-Network-of-Sterile-Fill-Finish-Sites.html

GLOBENEWSWIRE
17 Mar 2025

https://www.contractpharma.com/breaking-news/curia-refinances-senior-secured-credit-facilities/

CONTRACTPHARMA
10 Mar 2025

https://www.globenewswire.com/news-release/2025/03/07/3039263/0/en/Curia-Announces-Strategic-Refinancing-to-Support-Continued-Growth.html

GLOBENEWSWIRE
07 Mar 2025
Curia Commits to SBTi Net-Zero Standard
Curia Commits to SBTi Net-Zero Standard

08 Oct 2024

// PRESS RELEASE

https://curiaglobal.com/about-us/news/curia-commits-to-sbti-net-zero-standard/

PRESS RELEASE
08 Oct 2024

https://curiaglobal.com/about-us/news/curia-unveils-brand-refresh-at-cphi-ww-in-milan/

PRESS RELEASE
07 Oct 2024

Services

Upload your portfolio for free, ask us

Analytical

Click here to discover the service providers for Analytical

API Manufacturing

Click here to discover the service providers for API Manufacturing

Drug Product Manufacturing

Click here to discover the service providers for Drug Product Manufacturing

API & Drug Product Development

Click here to discover the service providers for API & Drug Product Development

Excipients

Click here to find the perfect excipient manufacturers by their capabilities

Excipients by Ingredients

Upload your portfolio for free, ask us

Excipients By applications

Upload your portfolio for free, ask us

Inspections and registrations

Upload your audits for free, ask us

ABOUT THIS PAGE

Contact Curia and get a quotation

Curia is a supplier offers 224 products (APIs, Excipients or Intermediates).

Find a price of Betamethasone Dipropionate bulk with DMF, CEP, JDMF offered by Curia

Find a price of Betamethasone Sodium Phosphate bulk with DMF, CEP, JDMF offered by Curia

Find a price of Clobetasol Propionate bulk with DMF, CEP, JDMF offered by Curia

Find a price of Cyclosporine bulk with DMF, CEP, JDMF offered by Curia

Find a price of Dorzolamide Hydrochloride bulk with DMF, CEP, JDMF offered by Curia

Find a price of Hydrocortisone bulk with DMF, CEP, JDMF offered by Curia

Find a price of Minocycline Hydrochloride bulk with DMF, CEP, JDMF offered by Curia

Find a price of Propofol bulk with DMF, CEP, JDMF offered by Curia

Find a price of Alclometasone Dipropionate bulk with DMF, JDMF offered by Curia

Find a price of Betamethasone Valerate bulk with CEP, JDMF offered by Curia

Find a price of Brimonidine Tartrate bulk with DMF, CEP offered by Curia

Find a price of Bromocriptine Mesylate bulk with DMF, CEP offered by Curia

Find a price of Budesonide bulk with DMF, CEP offered by Curia

Find a price of Chlorthalidone bulk with DMF, CEP offered by Curia

Find a price of Desogestrel bulk with DMF, CEP offered by Curia

Find a price of Dexamethasone bulk with CEP, JDMF offered by Curia

Find a price of Dexamethasone Sodium Phosphate bulk with DMF, CEP offered by Curia

Find a price of Dihydroergotamine Mesylate bulk with DMF, CEP offered by Curia

Find a price of Ergotamine Tartrate bulk with DMF, CEP offered by Curia

Find a price of Exemestane bulk with DMF, CEP offered by Curia

Find a price of Fentanyl bulk with DMF, CEP offered by Curia

Find a price of Fentanyl Citrate bulk with DMF, CEP offered by Curia

Find a price of Fluorometholone bulk with DMF, JDMF offered by Curia

Find a price of Flutamide bulk with DMF, CEP offered by Curia

Find a price of Fluticasone Propionate bulk with DMF, CEP offered by Curia

Find a price of Furosemide bulk with DMF, CEP offered by Curia

Find a price of Hydrocortisone Butyrate bulk with DMF, JDMF offered by Curia

Find a price of Mifepristone bulk with DMF, JDMF offered by Curia

Find a price of Mometasone Furoate bulk with DMF, CEP offered by Curia

Find a price of Olopatadine Hydrochloride bulk with DMF, JDMF offered by Curia

Find a price of Pancuronium Bromide bulk with DMF, CEP offered by Curia

Find a price of Pramipexole Dihydrochloride bulk with DMF, CEP offered by Curia

Find a price of Prednisolone Sodium Phosphate bulk with DMF, JDMF offered by Curia

Find a price of Ribavirin bulk with DMF, CEP offered by Curia

Find a price of Rocuronium Bromide bulk with DMF, CEP offered by Curia

Find a price of Testosterone bulk with DMF, CEP offered by Curia

Find a price of Triamcinolone Acetonide bulk with DMF, JDMF offered by Curia

Find a price of Ulipristal Acetate bulk with DMF, JDMF offered by Curia

Find a price of Vecuronium Bromide bulk with DMF, JDMF offered by Curia

Find a price of Alcaftadine bulk with DMF offered by Curia

Find a price of Altrenogest bulk with DMF offered by Curia

Find a price of Amphetamine Aspartate bulk with DMF offered by Curia

Find a price of Amphetamine Sulfate bulk with DMF offered by Curia

Find a price of Argatroban bulk with DMF offered by Curia

Find a price of Argatroban Monohydrate bulk with DMF offered by Curia

Find a price of Atropine Sulfate bulk with DMF offered by Curia

Find a price of Azelastine Hydrochloride bulk with DMF offered by Curia

Find a price of Aztreonam bulk with DMF offered by Curia

Find a price of Beclomethasone Dipropionate bulk with CEP offered by Curia

Find a price of Benztropine bulk with DMF offered by Curia

Find a price of Betamethasone bulk with JDMF offered by Curia

Find a price of Betamethasone Sodium Phosphate bulk with CEP offered by Curia

Find a price of Brexanolone bulk with DMF offered by Curia

Find a price of Butabarbital bulk with DMF offered by Curia

Find a price of Butorphanol Tartrate bulk with DMF offered by Curia

Find a price of Cannabidiol bulk with DMF offered by Curia

Find a price of Carbimazole bulk with CEP offered by Curia

Find a price of CAS 71-58-9 bulk with CEP offered by Curia

Find a price of Choline Fenofibrate bulk with DMF offered by Curia

Find a price of Cifenline bulk with JDMF offered by Curia

Find a price of Clascoterone bulk with DMF offered by Curia

Find a price of Cyclofenil bulk with JDMF offered by Curia

Find a price of Cyclosporine bulk with DMF offered by Curia

Find a price of Cyproterone Acetate bulk with CEP offered by Curia

Find a price of Deoxycholic Acid bulk with DMF offered by Curia

Find a price of Deucravacitinib bulk with DMF offered by Curia

Find a price of Dexamethasone bulk with JDMF offered by Curia

Find a price of Dexmethylphenidate bulk with DMF offered by Curia

Find a price of Dextroamphetamine Saccharate bulk with DMF offered by Curia

Find a price of Diatrizoate Meglumine bulk with DMF offered by Curia

Find a price of Diatrizoate Sodium bulk with DMF offered by Curia

Find a price of Dihydroergocristine bulk with CEP offered by Curia

Find a price of Dihydroergotoxine Mesylate bulk with DMF offered by Curia

Find a price of Drospirenone bulk with CEP offered by Curia

Find a price of Echothiophate Iodide bulk with DMF offered by Curia

Find a price of Epinephrine bulk with DMF offered by Curia

Find a price of Ethanolamine Oleate bulk with DMF offered by Curia

Find a price of Etonogestrel bulk with DMF offered by Curia

Find a price of Finasteride bulk with CEP offered by Curia

Find a price of Fludrocortisone Acetate bulk with DMF offered by Curia

Find a price of Fluoxymesterone bulk with DMF offered by Curia

Find a price of Hexetidine bulk with CEP offered by Curia

Find a price of Homoharringtonine bulk with DMF offered by Curia

Find a price of Hydrochloric Acid bulk with DMF offered by Curia

Find a price of Hydrocortisone bulk with DMF offered by Curia

Find a price of Hydrocortisone Acetate bulk with CEP offered by Curia

Find a price of Hydrocortisone Sodium Succinate bulk with CEP offered by Curia

Find a price of Hydroxychloroquine Sulphate bulk with DMF offered by Curia

Find a price of Isosorbide Mononitrate bulk with CEP offered by Curia

Find a price of L-Tartaric Acid bulk with DMF offered by Curia

Find a price of Lacosamide bulk with DMF offered by Curia

Find a price of Levocabastine bulk with CEP offered by Curia

Find a price of Loteprednol Etabonate bulk with DMF offered by Curia

Find a price of Mac321 bulk with DMF offered by Curia

Find a price of Mafenide bulk with DMF offered by Curia

Find a price of Mecamylamine bulk with DMF offered by Curia

Find a price of Mecamylamine Hydrochloride bulk with DMF offered by Curia

Find a price of Medroxyprogesterone Acetate bulk with DMF offered by Curia

Find a price of Methylphenidate Hydrochloride bulk with DMF offered by Curia

Find a price of Methylprednisolone Acetate bulk with DMF offered by Curia

Find a price of Metolazone bulk with DMF offered by Curia

Find a price of Milrinone bulk with JDMF offered by Curia

Find a price of Minocycline Hydrochloride bulk with DMF offered by Curia

Find a price of Monomethyl Fumarate bulk with DMF offered by Curia

Find a price of Mycophenolate Sodium bulk with DMF offered by Curia

Find a price of Naltrexone Methobromide bulk with DMF offered by Curia

Find a price of Nepafenac bulk with DMF offered by Curia

Find a price of Niflumic Acid bulk with CEP offered by Curia

Find a price of Norepinephrine Bitartrate bulk with DMF offered by Curia

Find a price of Olopatadine Hydrochloride bulk with DMF offered by Curia

Find a price of Oxandrolone bulk with DMF offered by Curia

Find a price of Pentetic Acid bulk with DMF offered by Curia

Find a price of Pentobarbital Sodium bulk with DMF offered by Curia

Find a price of Pethidine Hydrochloride bulk with DMF offered by Curia

Find a price of Pimecrolimus bulk with DMF offered by Curia

Find a price of Pralidoxime Chloride bulk with DMF offered by Curia

Find a price of Prednisone bulk with DMF offered by Curia

Find a price of Pyrazole Diamide, 29 bulk with DMF offered by Curia

Find a price of Regadenoson Monohydrate bulk with DMF offered by Curia

Find a price of Riboflavin 5 Phosphate Sodium bulk with DMF offered by Curia

Find a price of Ritalinic Acid bulk with DMF offered by Curia

Find a price of Ritonavir bulk with DMF offered by Curia

Find a price of Segesterone Acetate bulk with DMF offered by Curia

Find a price of Sirolimus bulk with DMF offered by Curia

Find a price of Sodium Oxybate bulk with DMF offered by Curia

Find a price of Succinate bulk with DMF offered by Curia

Find a price of Tapentadol bulk with DMF offered by Curia

Find a price of Testosterone Cypionate bulk with DMF offered by Curia

Find a price of Tetrahydrocannabinol bulk with DMF offered by Curia

Find a price of Thiazole bulk with DMF offered by Curia

Find a price of Ticlopidine bulk with DMF offered by Curia

Find a price of Travoprost bulk with DMF offered by Curia

Find a price of Triamcinolone Acetonide bulk with JDMF offered by Curia

Find a price of Trientine Hydrochloride bulk with DMF offered by Curia

Find a price of Upadacitinib bulk with DMF offered by Curia

Find a price of Viloxazine Hydrochloride bulk with DMF offered by Curia

Find a price of Vorinostat bulk with DMF offered by Curia

Find a price of Voxelotor bulk with DMF offered by Curia

Find a price of EBAB bulk with DMF offered by Curia

Find a price of KETOENAMINE bulk with DMF offered by Curia

Find a price of Isosorbide bulk offered by Curia

Find a price of 2-Bromo-Lysergic Acid Diethylamide bulk offered by Curia

Find a price of Abiraterone Acetate bulk offered by Curia

Find a price of Alogliptin Benzoate bulk offered by Curia

Find a price of Ambenonium Chloride bulk offered by Curia

Find a price of Argatroban bulk offered by Curia

Find a price of Aripiprazole bulk offered by Curia

Find a price of Artesunate bulk offered by Curia

Find a price of Atracurium Besylate bulk offered by Curia

Find a price of Atropine bulk offered by Curia

Find a price of Bamifylline bulk offered by Curia

Find a price of Belinostat bulk offered by Curia

Find a price of Betamethasone Acetate bulk offered by Curia

Find a price of Betamethasone Benzoate bulk offered by Curia

Find a price of Brigatinib bulk offered by Curia

Find a price of Cantharidin bulk offered by Curia

Find a price of Cetalkonium bulk offered by Curia

Find a price of Chlorthalidone bulk offered by Curia

Find a price of Citalopram Hydrobromide bulk offered by Curia

Find a price of Citalopram Hydrochloride bulk offered by Curia

Find a price of Clobetasol Propionate bulk offered by Curia

Find a price of Cyclosporine bulk offered by Curia

Find a price of Deflazacort bulk offered by Curia

Find a price of Dexmethylphenidate bulk offered by Curia

Find a price of Diethylamine Salicylate bulk offered by Curia

Find a price of Dihydroergocryptine bulk offered by Curia

Find a price of Dihydroergotamine Mesylate bulk offered by Curia

Find a price of Donepezil bulk offered by Curia

Find a price of Dorzolamide Hydrochloride bulk offered by Curia

Find a price of Enzalutamide bulk offered by Curia

Find a price of Ethinyl Estradiol bulk offered by Curia

Find a price of Etrasimod bulk offered by Curia

Find a price of Exemestane bulk offered by Curia

Find a price of Fluoxymesterone bulk offered by Curia

Find a price of Flurogestone Acetate bulk offered by Curia

Find a price of Flutamide bulk offered by Curia

Find a price of Ganaxolone bulk offered by Curia

Find a price of Hydroxyethyl Salicylate bulk offered by Curia

Find a price of Levonorgestrel bulk offered by Curia

Find a price of Lifitegrast bulk offered by Curia

Find a price of Lisdexamfetamine Dimesylate bulk offered by Curia

Find a price of Mangafodipir Trisodium bulk offered by Curia

Find a price of Medrogestone bulk offered by Curia

Find a price of Medroxyprogesterone Acetate bulk offered by Curia

Find a price of Melengestrol Acetate bulk offered by Curia

Find a price of Methylprednisolone bulk offered by Curia

Find a price of Methylprednisolone Aceponate bulk offered by Curia

Find a price of Methylprednisolone Acetate bulk offered by Curia

Find a price of Methylprednisolone Hemisuccinate bulk offered by Curia

Find a price of Methylprednisolone Sodium Succinate bulk offered by Curia

Find a price of Morniflumate bulk offered by Curia

Find a price of Nifuratel bulk offered by Curia

Find a price of Nikkomycin z bulk offered by Curia

Find a price of Obeticholic Acid bulk offered by Curia

Find a price of Paliperidone Palmitate bulk offered by Curia

Find a price of Palovarotene bulk offered by Curia

Find a price of Pralatrexate bulk offered by Curia

Find a price of Prednicarbate bulk offered by Curia

Find a price of Prednisolone bulk offered by Curia

Find a price of Primaquine Diphosphate bulk offered by Curia

Find a price of Propacetamol HCl bulk offered by Curia

Find a price of Resmetirom bulk offered by Curia

Find a price of Revumenib bulk offered by Curia

Find a price of Risperidone bulk offered by Curia

Find a price of Rocuronium Bromide bulk offered by Curia

Find a price of Samidorphan bulk offered by Curia

Find a price of Sarecycline bulk offered by Curia

Find a price of Serdexmethylphenidate bulk offered by Curia

Find a price of Sirolimus bulk offered by Curia

Find a price of Sodium Nitrite bulk offered by Curia

Find a price of Sodium Oxybate bulk offered by Curia

Find a price of Sodium Thiosulfate bulk offered by Curia

Find a price of Tacrolimus bulk offered by Curia

Find a price of Tamsulosin bulk offered by Curia

Find a price of Tedizolid bulk offered by Curia

Find a price of Testosterone Propionate bulk offered by Curia

Find a price of Tigecycline bulk offered by Curia

Find a price of Tolazoline HCl bulk offered by Curia

Find a price of Trenbolone Acetate bulk offered by Curia

Find a price of Vorinostat bulk offered by Curia

Find a price of Xylazine Hydrochloride bulk offered by Curia

Find a price of Zuranolone bulk offered by Curia

Find a price of SODIUM THIOSULFITE PENTAHYDRATE bulk offered by Curia

Find a price of bulk offered by Curia

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty